Hepatocellular carcinoma: Beyond screening

Journal of Hepatology

Volumn 39, Issue 2, 2003, Pages 269-271

  Sherman, Morris ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EDITORIAL; FOLLOW UP; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0042170184     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00249-6     Document Type: Editorial

References (13)

1. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-575.
2. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic careers of Hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432-438.
3. Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K, et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol 1999;30:125-130.
4. Giardina MG, Matarazzo M, Morante R, Lucariello A, Varriale A, Guardasole V, et al. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis. Cancer 1998;83:2468-2474.
5. Izuno K, Fujiyama S, Yamasaki K, Sato M, Stao T. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Hepatogastroenterology 1995;42:387-393.
6. Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. J Hepatol 2003;39:208-214.
7. International Working Party, Terminology of nodular lesions of the liver. Hepatology 1995;22:983-993.
8. Torzilli G, Miniagawa M, Takayama T, Inoue K, Hui AM, Kubota K, et al. Accurate pre-operative evaluation of liver mass lesions without fine needle biopsy. Hepatology 1999;30:8889-8893.
9. Levy I, Greig PD, Gallinger S, Langer B, Sherman M. Resection of hepatocellular carcinoma without preoperative tumor biopsy. Ann Surg 2001;234:206-209.
10. Nakashima T, Kojiro M. Hepatocellular carcinoma. Tokyo: Springer-Verlag; 1987.
11. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma: conclusions of he Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
12. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N. Cirrhosis or chronic hepatitis: evaluation of small (<2 cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003;226:550-555.
13. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long term results of percutaneous ethanol injection. Radiology 1995;197:101-108.